Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Palmitic acid
Price: Check
Purity: 98.0%
Stocking Period: 10 Day
Contact: Yang
Email: sales@echemcloud.com

Dayang Chem (Hangzhou) Co., Ltd.
China
Product Name: 2-(4-Chlorophenoxyacetylamino)-3-ethoxycarbonylthieno(2,3-b)quinuclidi ne
Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
Purity: 98.0%
Stocking Period: Inquiry
Contact: Ms Wang
Email: enquiry@dycnchem.com

112290-21-8

112290-21-8 structure

112290-21-8 structure

Name: 2-(4-Chlorophenoxyacetylamino)-3-ethoxycarbonylthieno(2,3-b)quinuclidi ne
Chemical Name: 2-(4-Chlorophenoxyacetylamino)-3-ethoxycarbonyl<2,3-b>quinuclidine
CAS Number: 112290-21-8
Molecular Formula: C₂₀H₂₁ClN₂O₄S
Molecular Weight: 420.91000
Create Date: 2017-08-05 15:30:15
Modify Date: 2025-08-26 20:25:48

Name	2-(4-Chlorophenoxyacetylamino)-3-ethoxycarbonyl<2,3-b>quinuclidine

Density	1.42g/cm3
Boiling Point	636ºC at 760mmHg
Molecular Formula	C₂₀H₂₁ClN₂O₄S
Molecular Weight	420.91000
Flash Point	338.4ºC
Exact Mass	420.09100
PSA	99.60000
LogP	5.00760
Vapour Pressure	4.48E-16mmHg at 25°C
Index of Refraction	1.648

CHEMICAL IDENTIFICATION

RTECS NUMBER :: KM5847900

CHEMICAL NAME :: 4H-4,7-Ethanothieno(2,3-b)pyridine-3-carboxylic acid, 5,6-dihydro-2-(((4-chlorophenoxy)acetyl)amino)-, ethyl ester

CAS REGISTRY NUMBER :: 112290-21-8

LAST UPDATED :: 199612

DATA ITEMS CITED :: 1

MOLECULAR FORMULA :: C20-H21-Cl-N2-O4-S

MOLECULAR WEIGHT :: 420.94

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: >2 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: PCJOAU Pharmaceutical Chemistry Journal (English Translation). Translation of KHFZAN. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No.1- 1967- Volume(issue)/page/year: 21,568,1987

4122-68-3 structure

4122-68-3

36860-49-8 structure

36860-49-8

~85%

112290-21-8 structure

112290-21-8

Literature: Kaminka, M. E.; Vorob'eva, V. Ya.; Nikitin, V. B.; Mikhlina, E. E.; Zhirnikova, M. L.; Yakhontov, L. N. Pharmaceutical Chemistry Journal, 1987 , vol. 21, # 8 p. 568 - 570 Khimiko-Farmatsevticheskii Zhurnal, 1987 , vol. 21, # 8 p. 945 - 948

3731-38-2 structure

3731-38-2

~%

112290-21-8 structure

112290-21-8

Literature: Kaminka, M. E.; Vorob'eva, V. Ya.; Nikitin, V. B.; Mikhlina, E. E.; Zhirnikova, M. L.; Yakhontov, L. N. Pharmaceutical Chemistry Journal, 1987 , vol. 21, # 8 p. 568 - 570 Khimiko-Farmatsevticheskii Zhurnal, 1987 , vol. 21, # 8 p. 945 - 948

105-56-6 structure

105-56-6

~%

112290-21-8 structure

112290-21-8

Literature: Kaminka, M. E.; Vorob'eva, V. Ya.; Nikitin, V. B.; Mikhlina, E. E.; Zhirnikova, M. L.; Yakhontov, L. N. Pharmaceutical Chemistry Journal, 1987 , vol. 21, # 8 p. 568 - 570 Khimiko-Farmatsevticheskii Zhurnal, 1987 , vol. 21, # 8 p. 945 - 948

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.